litlas
HomeLibrarySearchHistorySettingsPlans
Log inCreate account
HomeLibrarySearchHistorySettingsPlans
Log inCreate account

Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants

Authors: Christopher A. Eide, Matthew S. Zabriskie, Samantha L. Savage, Orlando Antelope, Nadeem A. Vellore, Hein Than, Anna Reister Schultz, Phillip M. Clair, Amber D. Bowler, Anthony D. Pomicter, Dongqing Yan, Anna V. Senina, Qiang Wang, Todd W. Kelley, Philippe Szankasi, Michael C. Heinrich, Jeffrey Tyner, Delphine Réa, Jean-Michel Cayuela, Dong‐Wook Kim, Cristina E. Tognon, Thomas O’Hare, Brian Druker, Michael W. Deininger - Cancer Cell 2019 cited by 245

litlas

Research-grade literature search and reference management for serious knowledge work.

HomeLibrarySearchHistorySettingsPlans
BlogAuthorsData sourcesFor librariansAPI documentationLegal noticeTerms of servicePrivacy policy